Two Diabetes Meds Don’t Slow Progression of Type 2 Diabetes in Youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body’s ability to make insulin.
Study Associates Obesity with Lower Breast Cancer Risk in Young Women
Young women with high body fat have a decreased chance of developing breast cancer before menopause, according to scientists at NIH and their collaborators.
Novel Drug Therapy Partially Restores Hearing in Mice
A small-molecule drug is one of the first to preserve hearing in a mouse model of an inherited form of progressive human deafness, report investigators at the University of Iowa, Iowa City, and NIDCD.
New Evidence That Viruses May Play a Role in Alzheimer’s
Analysis of large data sets from post-mortem brain samples of people with and without Alzheimer’s disease has revealed new evidence that viral species, particularly herpesviruses, may have a role in Alzheimer’s disease biology.
Teen Crash Risk Highest During First 3 Months After Getting Driver’s License
Teenage drivers are 8 times more likely to be involved in a collision or near miss during the first 3 months after getting a driver’s license, compared to the previous 3 months on a learner’s permit, suggests a study led by NICHD.
Scientists Watch Brain’s Lining Heal After Head Injury
Following head injury, the protective lining that surrounds the brain may get a little help from its friends: immune cells that spring into action to assist with repairs.
Male Depression May Lower Pregnancy Chances Among Infertile Couples
Among couples being treated for infertility, depression in the male partner was linked to lower pregnancy chances, while depression in the female partner was not found to influence the rate of live birth, according to a study funded by NIH.
International Study Suggests Combination Therapy May Prevent Stroke in Certain People
Results from an international clinical trial of more than 4,880 participants, published in the New England Journal of Medicine, show that combining clopidogrel and aspirin following a small stroke or minor stroke symptoms decreases risk of a new stroke, heart attack or other ischemic event within 90 days.